| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-43871 | |||
| BSA Free | NBP3-07981-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65338-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64761-100ug | |||
| BSA Free | NB100-64761-0.05mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76881SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-22542-50ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-49891-0.1mg | |||
| BSA Free | NBP2-49891-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70702 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43433-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70345 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74513 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76724-0.025mg | |||
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Analysis in human cerebral cortex and skeletal muscle tissues using NBP3-07981 antibody. Corresponding CD163 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0001.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Analysis in human cerebral cortex and skeletal muscle tissues using NBP3-07981 antibody. Corresponding CD163 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: CD163 Antibody (CL10652) [NBP3-07981] - Analysis in human spleen tissue.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Western-Blot-NBP3-07981-img0008.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Staining of rat cerebral cortex shows strong cytoplasmic positivity in perivascular macrophages.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0007.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Staining of human cerebellum shows moderate cytoplasmic positivity in microglia and strong staining in perivascular macrophages.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0002.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Staining of human cerebral cortex (Alzheimer's disease) shows strong cytoplasmic positivity in perivascular macrophages and in microglia.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0003.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Staining of human liver shows strong cytoplasmic positivity in Kupffer cells.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0004.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0005.jpg)
![Immunohistochemistry-Paraffin: CD163 Antibody (CL10652) [NBP3-07981] - Staining of human tonsil shows strong cytoplasmic positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/CD163-Antibody-CL10652-Immunohistochemistry-Paraffin-NBP3-07981-img0006.jpg)
![Flow Cytometry: Fc gamma RII/CD32 Antibody (AT10) [NB100-65338] - Analysis using the FITC conjugate of NB100-65338. Staining of human peripheral blood granulocytes.](http://images.novusbio.com/fullsize/Fc-gamma-RII-CD32-Antibody-AT10-Flow-Cytometry-NB100-65338-img0005.jpg "Flow Cytometry: Fc gamma RII/CD32 Antibody (AT10) [NB100-65338] - Analysis using the FITC conjugate of NB100-65338. Staining of human peripheral blood granulocytes.")
![Flow Cytometry: Fc gamma RII/CD32 Antibody (AT10) [NB100-65338] - Analysis using the Biotin conjugate of NB100-65338. Staining of human peripheral blood monocytes with mouse anti human CD32: BIOTIN.](http://images.novusbio.com/fullsize/Fc-gamma-RII-CD32-Antibody-AT10-Flow-Cytometry-NB100-65338-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0004.jpg "Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody , red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. Low power")
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 followed by horseradish peroxidase conjugated Goat anti Mouse IgG1 as a detection reagent. Medium power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunohistochemistry-Paraffin-NB100-64761-img0002.jpg)
![Flow Cytometry: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Staining of Con A activated rat spleen cells with Mouse anti Rat CD25: Biotin](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Flow-Cytometry-NB100-64761-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CD25/IL-2 R alpha Antibody (OX-39) [NB100-64761] - Rat lymph node cryosection with Mouse anti Rat CD25 antibody, red in A and Mouse anti Rat CD8, green in B. C is the merged image with nuclei counterstained blue using DAPI. High power](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-OX-39-Immunocytochemistry-Immunofluorescence-NB100-64761-img0001.jpg)
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0002.jpg "Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - Analysis of 20 ug of whole cell lysate from HeLa (Lane 1) and 293 (Lane 2) cells with anti-TRAIL-R3 at 1 ug/ml dilution. Image submitted by a verified customer review.")
![Western Blot: TRAILR3/TNFRSF10C Antibody [NBP1-76881] - HeLa whole cell lysate with TRAIL-R3 antibody (ED) at 1:500 dilution.](http://images.novusbio.com/fullsize/TRAILR3-TNFRSF10C-Antibody-Western-Blot-NBP1-76881-img0001.jpg)
![Immunocytochemistry/ Immunofluorescence: TRAILR3/TNFRSF10C Antibody - BSA Free [NBP1-76881] - Immunofluorescence of TRAILR3/TNFRSF10C in Hela cells with TRAILR3/TNFRSF10C antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76881_rabbit-polyclonal-trailr3-tnfrsf10c-antibody-2711202420324822.jpg)
![Immunocytochemistry/ Immunofluorescence: TRAILR3/TNFRSF10C Antibody - BSA Free [NBP1-76881] - Immunocytochemistry of TRAILR3/TNFRSF10C in HeLa cells with TRAILR3/TNFRSF10C antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76881_rabbit-polyclonal-trailr3-tnfrsf10c-antibody-271120242074690.jpg)
![Western Blot: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of 25 ug of Raji (Lane 1), Jurkat (Lane 2), and BAF-3 cell lysates (Lane 3) and a molecular weight protein ladder.](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Western-Blot-NBP2-22542-img0005.jpg "Western Blot: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of 25 ug of Raji (Lane 1), Jurkat (Lane 2), and BAF-3 cell lysates (Lane 3) and a molecular weight protein ladder.")
![Immunocytochemistry/Immunofluorescence: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 (green) showing staining in the cytoplasm of Raji cells (right) compared to a negative control without primary antibody (left).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Immunocytochemistry-Immunofluorescence-NBP2-22542-img0004.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in BAF-3 cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0003.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in PBMC cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0001.jpg)
![Flow Cytometry: CD58/LFA-3 Antibody (TS2/9) [NBP2-22542] - Analysis of CD58 in PBMC cells compared to an isotype control (blue).](http://images.novusbio.com/fullsize/CD58-LFA-3-Antibody-TS2-9-Flow-Cytometry-NBP2-22542-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Immunocytochemistry-Immunofluorescence-NB100-64729-img0006.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.")
![Flow Cytometry: Complement Component C1qA Antibody (3R9/2) [NB100-64729]](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Flow-Cytometry-NB100-64729-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0009.jpg "Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649 and Mouse IgG1 FITC isotype control. Figure B. Purified Rat anti Canine CD90 detected with Goat anti Rat IgG2a PE and Mouse anti Canine CD3 FITC.")
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse IgG1 isotype control. Figure B: APC conjugated rat anti-Canine CD4 and FITC conjugated mouse anti-Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0001.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A: RPE conjugated Rat anti-Dog CD4 and Mouse IgG1 isotype control labeled with Goat anti-Mouse FITC. Figure B: RPE conjugated Rat anti-Dog CD4 and Mouse anti-Dog CD3 labeled with Goat anti Mouse DyLight FITC.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0002.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. Alexa Fluor 700 conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0003.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG2a isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD4.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0004.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD4 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0005.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse IgG1 isotype control. Figure B. RPE conjugated Rat anti Canine CD8 and FITC conjugated Mouse anti Canine CD3.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0006.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat IgG1 isotype control. Figure B. FITC conjugated Mouse anti Canine CD3 and RPE conjugated Rat anti Canine CD8.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0007.jpg)
![Flow Cytometry: CD3 Antibody (CA17.2A12) [NBP2-49891] - Figure A. FITC conjugated Mouse anti Canine CD3 and purified Rat IgG2a isotype control detected with Goat anti Rat IgG2a DyLight 649. Figure B. FITC conjugated Mouse anti Canine CD3 and purified Mouse anti Canine CD90 detected with Goat anti Rat IgG2a DyLight 649.](http://images.novusbio.com/fullsize/CD3-Antibody-CA17-2A12-Flow-Cytometry-NBP2-49891-img0008.jpg)
![Western Blot: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Fc gamma RI/CD64.](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-OTI1A8-Western-Blot-NBP2-45625-img0005.jpg "Western Blot: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Fc gamma RI/CD64.")
![Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - Fc gamma RI/CD64 Antibody (1A8) [NBP2-45625] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY Fc gamma RI/CD64.](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-OTI1A8-Immunocytochemistry-Immunofluorescence-NBP2-45625-img0001.jpg)
![Immunohistochemistry: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - Analysis of Adenocarcinoma of Human endometrium tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-OTI1A8-Immunohistochemistry-NBP2-45625-img0004.jpg)
![Flow Cytometry: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - analysis of living 293T cells transfected with FCGR1A overexpression plasmid .](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-OTI1A8-Flow-Cytometry-NBP2-45625-img0006.jpg)
![Immunohistochemistry: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-OTI1A8-Immunohistochemistry-NBP2-45625-img0002.jpg)
![Immunohistochemistry: Fc gamma RI/CD64 Antibody (OTI1A8) [NBP2-45625] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-OTI1A8-Immunohistochemistry-NBP2-45625-img0003.jpg)
![Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Human colon tissue stained with . IHC-P image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Immunohistochemistry-Paraffin-NBP1-43433-img0007.jpg "Immunohistochemistry-Paraffin: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Human colon tissue stained with . IHC-P image submitted by a verified customer review.")
![Flow Cytometry: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Analysis using the PerCP/Cy5.5 conjugate of NBP1-43433. Staining of normal human peripheral blood cells with Anti-Human CD19 FITC and Anti-Human CD23 PerCP-Cy5.5. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Flow-Cytometry-NBP1-43433-img0005.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Staining of normal human peripheral blood cells with 0.5 ug of Mouse IgG1 kappa Isotype Control Purified (open histogram) or 0.25 ug of Anti-Human CD23 Purified (filled histogram) followed by Anti-Mouse IgG FITC. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Flow-Cytometry-NBP1-43433-img0001.jpg)
![Flow Cytometry: CD23/Fc epsilon RII Antibody (EBVCS2) [NBP1-43433] - Analysis using the PE conjugate of NBP1-43433. Analysis of human peripheral blood leukocytes using CD23 PE conjugate. This can be used at less than or equal to 0.5 ug per test. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test.](http://images.novusbio.com/fullsize/CD23-Fc-epsilon-RII-Antibody-EBVCS2-Flow-Cytometry-NBP1-43433-img0004.jpg)
![Western Blot: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD1c .](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Western-Blot-NBP2-46123-img0007.jpg "Western Blot: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD1c .")
![Immunocytochemistry/Immunofluorescence: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY CD1C.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunofluorescence-NBP2-46123-img0009.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0006.jpg)
![Western Blot: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Jurkat extracts (10ug).](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Western-Blot-NBP2-46123-img0008.jpg)
![Immunocytochemistry/Immunofluorescence: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunofluorescence-NBP2-46123-img0002.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0003.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0004.jpg)
![Immunohistochemistry: CD1c/BDCA-1 Antibody (OTI2F4) [NBP2-46123] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CD1c-BDCA-1-Antibody-OTI2F4-Immunohistochemistry-NBP2-46123-img0005.jpg)
![Western Blot: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TIA1.](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Western-Blot-NBP2-46132-img0008.jpg "Western Blot: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY TIA1.")
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0007.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0001.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0002.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0003.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0004.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0005.jpg)
![Immunohistochemistry: TIA1 Antibody (1D7) [NBP2-46132] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/TIA1-Antibody-1D7-Immunohistochemistry-NBP2-46132-img0006.jpg)
![TIA1 Antibody (OTI1D7)[NBP2-46132]Simple Western� analysis of endogenous protein TLE1 from A549 lysates (0.2 mg/mL) using TLE1 Mouse Monoclonal Antibody . The virtual lane view (left) shows the target (as indicated) at 1:50 dilution of primary antibody. The corresponding electropherogram view (right) plots chemiluminescence by molecular weight along the capillary at a 1:50 dilution of primary antibody. This experiment was performed under reducing conditions on the Jess� Simple Western instrument from ProteinSimple, a Bio-Techne brand, using the 12�230 kDa Separation Module.](http://images.novusbio.com/fullsize/nbp2-46132_mouse-tia1-mab-oti1d7-simple-western-1311202512362223.jpg%253fstore=america&image-type=image)
![Western Blot: IL-22R alpha 1 Antibody [NBP1-76724] - Analysis of IL-22 receptor expression in human HepG2 cell lysate with IL-22 receptor antibody at (A) 0.5 and (B) 1 ug /ml.](http://images.novusbio.com/fullsize/IL-22R-alpha-1-Antibody-Western-Blot-NBP1-76724-img0010.jpg "Western Blot: IL-22R alpha 1 Antibody [NBP1-76724] - Analysis of IL-22 receptor expression in human HepG2 cell lysate with IL-22 receptor antibody at (A) 0.5 and (B) 1 ug /ml.")
![Immunohistochemistry: IL-22R alpha 1 Antibody [NBP1-76724] - Staining of rat kidney tissue with antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/IL-22R-alpha-1-Antibody-Immunohistochemistry-NBP1-76724-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: IL-22R alpha 1 Antibody [NBP1-76724] - Immunofluorescence:HepG2 cells with IL-22RA1 receptor antibody at 10 ug/ml.](http://images.novusbio.com/fullsize/IL-22R-alpha-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-76724-img0008.jpg)
![Immunocytochemistry/ Immunofluorescence: IL-22R alpha 1 Antibody - BSA Free [NBP1-76724] - Immunofluorescence of IL-22R alpha 1 in rat kidney tissue with IL-22R alpha 1 antibody at 20 u/ml.](http://images.novusbio.com/fullsize/nbp1-76724_rabbit-polyclonal-il-22r-alpha-1-antibody-2711202419183815.gif)
![Immunocytochemistry/ Immunofluorescence: IL-22R alpha 1 Antibody - BSA Free [NBP1-76724] - Immunofluorescence of IL-22 receptor in HepG2 cells with IL-22 receptor antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76724_rabbit-polyclonal-il-22r-alpha-1-antibody-271120241951401.jpg)